Category: News

News

Occlutech’s board member Tor Peters featured in Swedish newspapers talking about Occlutech’s journey

Dagens Industri Sydsvenskan

Read More
NewsASD

Summary: ASD randomized comparative study

Download PDF

Read More
NewsPFO

Summary: Dutch long term PFO study

Download PDF

Read More
NewsAFR

Viomedo: Studie zur Bewertung der Sicherheit und Wirksamkeit des “Atrial Flow Regulators“ bei Patienten mit Herzschwäche (PRELIEVE-Studie)

Read more

Read More
NewsAFR

Viomedo: Studie zur Bewertung der Wirksamkeit und Sicherheit des „Atrial Flow Regulators“ bei Patienten mit Lungenhochdruck (PROPHET-Studie)

Read more

Read More
NewsPFO

New Guideline Recommendations US and Germany

Stroke experts around the globe formulate demands for updated stroke guidelines in favor of PFO closure.

Read More
NewsASDPFO

Die Helfer des Herzens

Interview mit Tor Peters, CEO Occlutech

Read More
NewsPFO

Ein Schirmchen schützt vor einem Schlaganfall

Stader Tagesblatt, April 22 2018 (German)

A PFO Success-Story: 0 to 28 since November 2017

Read More
NewsPmVSD

Occlutech obtains European CE Mark for its novel PmVSD Occluder

Schaffhausen, Switzerland – Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a specifically designed implant indicated for the minimally invasive closure of perimembranous ventricular septal defects…

Read More
News

Occlutech obtains European CE mark approval for its LAA Occluder

Schaffhausen, Switzerland -Occlutech, a leading innovator of implants to treat structural heart disease,today announced that it has obtained European CE Mark approval for its Left Atrial Appendix, (LAA), occluder. The device is a specifically designed implant for theminimally invasive closure of the LAA, a procedure that minimizes the risk of strokes in patients suffering from atrial fibrillation…

Read More